The role of brain cholesterol in Alzheimer’s disease (AD) is currently a matter of debate. Experimental evidence suggests that reducing circulating and brain cholesterol protects against AD, however recent data indicate that low membrane cholesterol results in neurodegeneration and that the cholesterol synthesis catalyst seladin-1 is down-regulated in AD-affected brain regions. We previously reported a significant correlation between resistance to amyloid toxicity and content of membrane cholesterol in differing cultured cell types. Here we provide evidence that A42 pre-fibrillar aggregates accumulate more slowly and in reduced amount at the plasma membrane of human SH-SY5Y neuroblastoma cells overexpressing seladin-1 or treated with PEG-cholesterol than at the membrane of control cells. The accumulation was significantly increased in cholesterol-depleted cells following treatment with the specific seladin-1 inhibitor 5,22Echolestadien- 3-ol or with methyl--cyclodextrin. The resistance to amyloid toxicity and the early cytosolic Ca2+ rise following exposure to A42 aggregates were increased and prevented, respectively, by increasing membrane cholesterol whereas the opposite effects were found in cholesterol-depleted cells. These results suggest that seladin-1-dependent cholesterol synthesis reduces membrane-aggregate interaction and cell damage associated to amyloid-induced imbalance of cytosolic Ca2+. Our findings extend recently reported data indicating that seladin-1 overexpression directly enhances the resistance to A toxicity featuring seladin-1/DHCR 24 as a possible new susceptibility gene for sporadic AD.

Seladin-1/dhcr24 protects neuroblastoma cells against aβ toxicity by increasing membrane cholesterol content / C.Cecchi; F.Rosati; A.Pensalfini; L.Formigli; D.Nosi; G.Liguri; F.Dichiara; M.Morello; G.Danza; G.Pieraccini; A.Peri; M.Serio; M.Stefani. - In: JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. - ISSN 1582-1838. - STAMPA. - 12:(2008), pp. 1990-2002.

Seladin-1/dhcr24 protects neuroblastoma cells against aβ toxicity by increasing membrane cholesterol content

CECCHI, CRISTINA;ROSATI, FABIANA;FORMIGLI, LUCIA;NOSI, DANIELE;LIGURI, GIANFRANCO;DANZA, GIOVANNA;G. Pieraccini;PERI, ALESSANDRO;SERIO, MARIO;STEFANI, MASSIMO
2008

Abstract

The role of brain cholesterol in Alzheimer’s disease (AD) is currently a matter of debate. Experimental evidence suggests that reducing circulating and brain cholesterol protects against AD, however recent data indicate that low membrane cholesterol results in neurodegeneration and that the cholesterol synthesis catalyst seladin-1 is down-regulated in AD-affected brain regions. We previously reported a significant correlation between resistance to amyloid toxicity and content of membrane cholesterol in differing cultured cell types. Here we provide evidence that A42 pre-fibrillar aggregates accumulate more slowly and in reduced amount at the plasma membrane of human SH-SY5Y neuroblastoma cells overexpressing seladin-1 or treated with PEG-cholesterol than at the membrane of control cells. The accumulation was significantly increased in cholesterol-depleted cells following treatment with the specific seladin-1 inhibitor 5,22Echolestadien- 3-ol or with methyl--cyclodextrin. The resistance to amyloid toxicity and the early cytosolic Ca2+ rise following exposure to A42 aggregates were increased and prevented, respectively, by increasing membrane cholesterol whereas the opposite effects were found in cholesterol-depleted cells. These results suggest that seladin-1-dependent cholesterol synthesis reduces membrane-aggregate interaction and cell damage associated to amyloid-induced imbalance of cytosolic Ca2+. Our findings extend recently reported data indicating that seladin-1 overexpression directly enhances the resistance to A toxicity featuring seladin-1/DHCR 24 as a possible new susceptibility gene for sporadic AD.
2008
12
1990
2002
C.Cecchi; F.Rosati; A.Pensalfini; L.Formigli; D.Nosi; G.Liguri; F.Dichiara; M.Morello; G.Danza; G.Pieraccini; A.Peri; M.Serio; M.Stefani
File in questo prodotto:
File Dimensione Formato  
cecchi.pdf

accesso aperto

Tipologia: Versione finale referata (Postprint, Accepted manuscript)
Licenza: Open Access
Dimensione 633.31 kB
Formato Adobe PDF
633.31 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/315949
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 65
  • ???jsp.display-item.citation.isi??? 54
social impact